Tue, Sep 23, 2014, 12:28 AM EDT - U.S. Markets open in 9 hrs 2 mins

Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • sh3ngrace sh3ngrace Jan 29, 2013 11:31 AM Flag

    Earning for Q4, 201

    Market expects at -$0.37. I think PACB can easily beats the expectation. Does any one have a wisper number?

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • IMHO, any speculator who plays biotech on the basis of "earnings" is on a fool's errand. That being said, PACB has recovered nicely after a disappointing product launch and is leading the way with its 3rd gen sequencing technology.

      Personally, I find this an interesting technical play (GREAT chart pattern) and more than a hope-and-a-prayer takeover play (Roche). As Roche's Franz Humer stated: "There are several alternatives to get hold of gene-sequencing technology. I'm not worried about that," he said, without giving more details.

      With a market cap of ~$150M and average trading volume under 500,000 (and FAR less during this recent consolidation phase), PACB is flying way under the radar of the vast majority of investors (and speculators). It won't take much to move the share price.

      Combine all of that with significant insider buying and PACB appears to me to have a very attractive risk - to - reward profile.

      One man's opinion.

      Good luck.

 
PACB
5.11+0.10(+2.00%)Sep 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Sigma-Aldrich Corporation
NasdaqGSMon, Sep 22, 2014 4:15 PM EDT
Herbalife Ltd.
NYSEMon, Sep 22, 2014 4:01 PM EDT